中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
25期
9-11
,共3页
米青%季存栋%陈丽萍%李霞%戚丽娜
米青%季存棟%陳麗萍%李霞%慼麗娜
미청%계존동%진려평%리하%척려나
氯雷他定%小儿%喘息性支气管炎%临床疗效
氯雷他定%小兒%喘息性支氣管炎%臨床療效
록뢰타정%소인%천식성지기관염%림상료효
Loratadine%Children%Asthmatic bronchitis%Clinical curative effect
目的:探讨氯雷他定在治疗小儿喘息性支气管炎中临床疗效。方法将随机选取该院2010年1月-2014年5月儿科住院治疗的小儿喘息性支气管炎100例,随机分为对照组50例(常规治疗);观察组50例(常规治疗+氯雷他定治疗),详细将两组患儿治疗前后外周血嗜酸性粒细胞、WBC、IL-2、4、5水平进行记录;两组患儿治疗过程中发热、咳嗽、咯痰、咽痛、胸片阳性缓解时间进行记录;两组患儿治疗后疗效比较进行记录分析。结果干预前,两组患儿的血WBC、IL-2、4、5水平比较,差异无统计学意义(P>0.05);干预后,两组患儿的血WBC、IL-2、4、5水平均显著下降,观察组患者指标显著低于对照组患儿,差异有统计学意义(P<0.05)。观察组患儿治疗过程中发热、咳嗽、咯痰、咽痛、胸片阳性缓解时间显著低于对照组患儿,差异有统计学意义(P<0.05)。治疗7 d后,观察组患儿的临床总有效率98%,显著高于对照组78%,差异有统计学意义(P<0.05)。结论氯雷他定可有效干预患儿WBC、嗜酸性粒细胞、IL-2、IL-4、IL-5水平,有效缩短患儿治疗时间,氯雷他定治疗治疗小儿喘息性支气管炎疗效确切。
目的:探討氯雷他定在治療小兒喘息性支氣管炎中臨床療效。方法將隨機選取該院2010年1月-2014年5月兒科住院治療的小兒喘息性支氣管炎100例,隨機分為對照組50例(常規治療);觀察組50例(常規治療+氯雷他定治療),詳細將兩組患兒治療前後外週血嗜痠性粒細胞、WBC、IL-2、4、5水平進行記錄;兩組患兒治療過程中髮熱、咳嗽、咯痰、嚥痛、胸片暘性緩解時間進行記錄;兩組患兒治療後療效比較進行記錄分析。結果榦預前,兩組患兒的血WBC、IL-2、4、5水平比較,差異無統計學意義(P>0.05);榦預後,兩組患兒的血WBC、IL-2、4、5水平均顯著下降,觀察組患者指標顯著低于對照組患兒,差異有統計學意義(P<0.05)。觀察組患兒治療過程中髮熱、咳嗽、咯痰、嚥痛、胸片暘性緩解時間顯著低于對照組患兒,差異有統計學意義(P<0.05)。治療7 d後,觀察組患兒的臨床總有效率98%,顯著高于對照組78%,差異有統計學意義(P<0.05)。結論氯雷他定可有效榦預患兒WBC、嗜痠性粒細胞、IL-2、IL-4、IL-5水平,有效縮短患兒治療時間,氯雷他定治療治療小兒喘息性支氣管炎療效確切。
목적:탐토록뢰타정재치료소인천식성지기관염중림상료효。방법장수궤선취해원2010년1월-2014년5월인과주원치료적소인천식성지기관염100례,수궤분위대조조50례(상규치료);관찰조50례(상규치료+록뢰타정치료),상세장량조환인치료전후외주혈기산성립세포、WBC、IL-2、4、5수평진행기록;량조환인치료과정중발열、해수、각담、인통、흉편양성완해시간진행기록;량조환인치료후료효비교진행기록분석。결과간예전,량조환인적혈WBC、IL-2、4、5수평비교,차이무통계학의의(P>0.05);간예후,량조환인적혈WBC、IL-2、4、5수평균현저하강,관찰조환자지표현저저우대조조환인,차이유통계학의의(P<0.05)。관찰조환인치료과정중발열、해수、각담、인통、흉편양성완해시간현저저우대조조환인,차이유통계학의의(P<0.05)。치료7 d후,관찰조환인적림상총유효솔98%,현저고우대조조78%,차이유통계학의의(P<0.05)。결론록뢰타정가유효간예환인WBC、기산성립세포、IL-2、IL-4、IL-5수평,유효축단환인치료시간,록뢰타정치료치료소인천식성지기관염료효학절。
Objective To investigate the curative effect of Loratadine in the treatment of asthmatic bronchitis in children. Methods 100 children with asthmatic bronchitis hospitalized in Department of Pediatrics of our hospital from January 2010 to May 2014 were randomly divided into the control group and the observation group with 50 children in each. The control group was given con-ventional treatment, and the observation group was given Loratadine combined with conventional treatment. The levels of eosinophile granulocyte, WBC, IL-2, IL-4 and IL-5 in peripheral blood of the two groups were recorded in detail before and after treatment. The relief time of fever, cough, expectoration, sore throat, positive chest X-ray of the two groups during the treatment was recorded. And the efficacy of the two groups was recorded and analyzed and compared after treatment. Results After interven-tion, the level of WBC, IL-2, IL-4, IL-5 in both groups decreased significantly, moreover, that was much lower in the observation group than in the control group, respectively with statistically significant difference(P<0.05). The relief time of fever, cough, expec-toration, sore throat, positive chest X-ray during the treatment was much shorter in the observation group than that in the control group, respectively, with statistically significant difference (P<0.05). After 7 d of treatment, The overall clinical response rate was much higher in the observation group than in the control group(98%vs 78%) with statistically significant difference(P<0.05). Con-clusion For children with asthmatic bronchitis, Loratadine can effectively improve the level of WBC, eosinophile granulocyte, IL-2, IL-4 and IL-5 levels and shorten the duration of treatment with exact curative effect.